NASDAQ:BNR Burning Rock Biotech Q2 2026 Earnings Report $15.82 -0.43 (-2.65%) Closing price 04:00 PM EasternExtended Trading$16.12 +0.30 (+1.90%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Burning Rock Biotech EPS ResultsActual EPSN/AConsensus EPS -$2.29Beat/MissN/AOne Year Ago EPSN/ABurning Rock Biotech Revenue ResultsActual RevenueN/AExpected Revenue$19.21 millionBeat/MissN/AYoY Revenue GrowthN/ABurning Rock Biotech Announcement DetailsQuarterQ2 2026Date9/2/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesSlide DeckPress Release (6-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(6-K) Burning Rock Biotech Earnings HeadlinesOnconetix (NASDAQ:ONCO) & Burning Rock Biotech (NASDAQ:BNR) Financial ComparisonSeptember 27, 2026 | americanbankingnews.comBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 5 at 1:00 AM | Chaikin Analytics (Ad)Burning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comBurning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | finanznachrichten.deBurning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | globenewswire.comSee More Burning Rock Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email. Email Address About Burning Rock BiotechBurning Rock Biotech (NASDAQ:BNR) Limited is a China-based biotechnology company focused on precision oncology. The company develops and commercializes cancer testing products based primarily on next-generation sequencing and liquid biopsy technologies, which analyze tumor-related genetic material found in blood and other biological samples. Its activities span the cancer-care process, including early cancer detection, diagnosis, treatment selection and disease monitoring. Burning Rock provides testing solutions intended to help healthcare professionals identify cancer-associated mutations, assess patients’ potential responses to targeted therapies and monitor treatment outcomes or disease recurrence. It also offers testing and related services for pharmaceutical companies conducting oncology drug development and clinical research. Founded in 2014 and headquartered in Guangzhou, China, Burning Rock has built its business around serving hospitals, physicians, pharmaceutical companies and research institutions. The company’s commercial operations have primarily focused on the Chinese market, while its research and development activities support broader applications of precision medicine in oncology. Burning Rock’s American depositary shares began trading on the Nasdaq under the symbol BNR in 2020.View Burning Rock Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunMarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last Longer Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
